AI assistant
Edwards Lifesciences Corp — Director's Dealing 2012
Jul 31, 2012
30042_dirs_2012-07-31_df6d6637-328f-426a-80c6-32038c75eaf9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2012-07-27
Reporting Person: WANG HUIMIN (CVP, Japan & Intercontinental)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-07-27 | Common Stock | S | 2404.0000 | $102.7900 | Disposed | 47167.1278 | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $102.78 to $102.79. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.